<ARTICLE> 5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company for the period ended 6/30/98 </LEGEND> <MULTIPLIER> 1000000 <PERIOD-TYPE> 6-Mos <FISCAL-YEAR-END> Dec-31-1998 <F1> <PERIOD-END> Jun-30-1998 <CASH> 1005 <SECURITIES> 308 <RECEIVABLES> 3122 <F2> <ALLOWANCES> 0 <INVENTORY> 1812 <CURRENT-ASSETS> 7313 <PP&E> 7134 <DEPRECIATION> 2929 <TOTAL-ASSETS> 14593 <CURRENT-LIABILITIES> 4601 <BONDS> 1336 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 109 <OTHER-SE> 7135 <TOTAL-LIABILITY-AND-EQUITY> 14593 <SALES> 8876 <TOTAL-REVENUES> 8876 <CGS> 2358 <TOTAL-COSTS> 2358 <OTHER-EXPENSES> 1980 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 78 <INCOME-PRETAX> 2456 <INCOME-TAX> 694 <INCOME-CONTINUING> 1762 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1762 <EPS-PRIMARY> 1.77 <EPS-DILUTED> 1.73 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.